240 Impact of AUC/MIC-based Versus Trough-based Vancomycin Monitoring on Acute Kidney Injury and Therapeutic Attainment in Hospitalized Adults
Journal of the American Pharmacists Association · 2026-07 · 66 (4) · 103272
DOI: 10.1016/j.japh.2026.103272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Pharmacists Association, 2026-07. Verfasst von S. Mohamed und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mohamed, S., & Whittaker, A. (2026). 240 Impact of AUC/MIC-based Versus Trough-based Vancomycin Monitoring on Acute Kidney Injury and Therapeutic Attainment in Hospitalized Adults. Journal of the American Pharmacists Association, 66(4), 103272. https://doi.org/10.1016/j.japh.2026.103272
Vancouver
Mohamed S, Whittaker A. 240 Impact of AUC/MIC-based Versus Trough-based Vancomycin Monitoring on Acute Kidney Injury and Therapeutic Attainment in Hospitalized Adults. Journal of the American Pharmacists Association. 2026;66(4):103272. doi:10.1016/j.japh.2026.103272
BibTeX
@article{Mohamed2026,
author = {Mohamed, S. and Whittaker, A.},
title = {240 Impact of AUC/MIC-based Versus Trough-based Vancomycin Monitoring on Acute Kidney Injury and Therapeutic Attainment in Hospitalized Adults},
journal = {Journal of the American Pharmacists Association},
year = {2026},
volume = {66},
number = {4},
pages = {103272},
doi = {10.1016/j.japh.2026.103272}
}
EUVIMED